Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2025)

Immatics (IMTX) reported Non-Current Deffered Revenue of $21.6 million for Q4 2025, down 40.88% on a YoY basis from $36.5 million in Q4 2024, and down 40.88% sequentially from $36.5 million in Q4 2024.

Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Non-Current Deffered Revenue data on file, last reported at $21.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deffered Revenue fell 40.88% year-over-year to $21.6 million; the trailing twelve-month figure through Dec 2025 stood at $21.6 million (down 40.88% YoY), and the FY2025 full-year result was $20.9 million, down 43.34% from the prior year.
  • Non-Current Deffered Revenue declined to $21.6 million in Q4 2025, from $36.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $124.3 million in Q4 2023 to a low of $21.6 million in Q4 2025.
  • A 5-year average of $63.0 million and a median of $55.2 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue surged 60.82% in 2023 and slumped 70.63% in 2024, its largest moves.
  • Tracing IMTX's Non-Current Deffered Revenue over 5 years: stood at $55.2 million in 2021, then soared by 40.1% to $77.3 million in 2022, then surged by 60.82% to $124.3 million in 2023, then slumped by 70.63% to $36.5 million in 2024, then sank by 40.88% to $21.6 million in 2025.
  • Business Quant data shows IMTX's Non-Current Deffered Revenue at $21.6 million in Q4 2025, $36.5 million in Q4 2024, and $124.3 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - 21.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 21.58 Mn
Dec 31, 2024 36.50 Mn
Dec 31, 2023 124.30 Mn
Dec 31, 2022 77.29 Mn
Dec 31, 2021 55.17 Mn
Dec 31, 2020 101.91 Mn
Dec 31, 2019 94.61 Mn